339 related articles for article (PubMed ID: 28432523)
1. Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtyping.
Stekhoven D; Scherer A; Nissen MJ; Grobéty V; Yawalkar N; Villiger PM; Möller B;
Clin Rheumatol; 2017 Sep; 36(9):2035-2043. PubMed ID: 28432523
[TBL] [Abstract][Full Text] [Related]
2. A classification study of clinical subsets in an inception cohort of early psoriatic peripheral arthritis--'DIP or not DIP revisited'.
Kane D; Stafford L; Bresnihan B; FitzGerald O
Rheumatology (Oxford); 2003 Dec; 42(12):1469-76. PubMed ID: 12867577
[TBL] [Abstract][Full Text] [Related]
3. Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA.
Iannone F; Lopriore S; Bucci R; Scioscia C; Anelli MG; Notarnicola A; Lapadula G
Scand J Rheumatol; 2015 May; 44(3):192-9. PubMed ID: 25564882
[TBL] [Abstract][Full Text] [Related]
4. Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission.
Ramírez J; Inciarte-Mundo J; Cuervo A; Ruiz-Esquide V; Hernández MV; Sanmartí R; Cañete JD
Clin Exp Rheumatol; 2017; 35(1):74-79. PubMed ID: 27749227
[TBL] [Abstract][Full Text] [Related]
5. Swollen joint count in psoriatic arthritis is associated with progressive radiological damage in hands and feet.
Simon P; Pfoehler C; Bergner R; Schreiber M; Pfreundschuh M; Assmann G
Clin Exp Rheumatol; 2012; 30(1):45-50. PubMed ID: 22274638
[TBL] [Abstract][Full Text] [Related]
6. Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis.
Eder L; Thavaneswaran A; Chandran V; Gladman DD
Ann Rheum Dis; 2014 Jun; 73(6):1007-11. PubMed ID: 23619157
[TBL] [Abstract][Full Text] [Related]
7. The Psoriatic Arthritis Registry of Turkey: results of a multicentre registry on 1081 patients.
Kalyoncu U; Bayindir Ö; Ferhat Öksüz M; Doğru A; Kimyon G; Tarhan EF; Erden A; Yavuz Ş; Can M; Çetin GY; Kılıç L; Küçükşahin O; Omma A; Ozisler C; Solmaz D; Bozkirli ED; Akyol L; Pehlevan SM; Gunal EK; Arslan F; Yılmazer B; Atakan N; Aydın SZ;
Rheumatology (Oxford); 2017 Feb; 56(2):279-286. PubMed ID: 27794533
[TBL] [Abstract][Full Text] [Related]
8. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.
Szentpetery A; McKenna MJ; Murray BF; Ng CT; Brady JJ; Morrin M; Radovits B; Veale DJ; Fitzgerald O
J Rheumatol; 2013 May; 40(5):653-62. PubMed ID: 23457381
[TBL] [Abstract][Full Text] [Related]
9. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G
J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
[TBL] [Abstract][Full Text] [Related]
10. Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs.
Perrotta FM; Marchesoni A; Lubrano E
J Rheumatol; 2016 Feb; 43(2):350-5. PubMed ID: 26669925
[TBL] [Abstract][Full Text] [Related]
11. Psoriatic Arthritis Mutilans: Characteristics and Natural Radiographic History.
Jadon DR; Shaddick G; Tillett W; Korendowych E; Robinson G; Waldron N; Cavill C; McHugh NJ
J Rheumatol; 2015 Jul; 42(7):1169-76. PubMed ID: 25979723
[TBL] [Abstract][Full Text] [Related]
12. The Role of Tumor Necrosis Factor-α Blockers in Psoriatic Disease. Therapeutic Options in Psoriatic Arthritis.
Addimanda O; Possemato N; Caruso A; Pipitone N; Salvarani C
J Rheumatol Suppl; 2015 Nov; 93():73-8. PubMed ID: 26523063
[TBL] [Abstract][Full Text] [Related]
13. Patient's Global Assessment as an Outcome Measure for Psoriatic Arthritis in Clinical Practice: A Surrogate for Measuring Low Disease Activity?
Lubrano E; Perrotta FM; Parsons WJ; Marchesoni A
J Rheumatol; 2015 Dec; 42(12):2332-8. PubMed ID: 26523033
[TBL] [Abstract][Full Text] [Related]
14. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.
Paramarta JE; De Rycke L; Ambarus CA; Tak PP; Baeten D
Rheumatology (Oxford); 2013 Oct; 52(10):1873-8. PubMed ID: 23861532
[TBL] [Abstract][Full Text] [Related]
15. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience.
Kane D; Stafford L; Bresnihan B; FitzGerald O
Rheumatology (Oxford); 2003 Dec; 42(12):1460-8. PubMed ID: 14523223
[TBL] [Abstract][Full Text] [Related]
16. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
Michelsen B; Kristianslund EK; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK
Ann Rheum Dis; 2017 Apr; 76(4):708-711. PubMed ID: 27707730
[TBL] [Abstract][Full Text] [Related]
17. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
Theander E; Husmark T; Alenius GM; Larsson PT; Teleman A; Geijer M; Lindqvist UR
Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
[TBL] [Abstract][Full Text] [Related]
18. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?
Kilic G; Kilic E; Nas K; Kamanlı A; Tekeoglu İ
Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept.
Lubrano E; Spadaro A; Marchesoni A; Olivieri I; Scarpa R; D'Angelo S; Salvarani C; Mathieu A; Cauli A; Ferrara N; Helliwell P
Clin Exp Rheumatol; 2011; 29(1):80-4. PubMed ID: 21345296
[TBL] [Abstract][Full Text] [Related]
20. DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. The Swedish Early Psoriatic Arthritis Cohort.
Lindqvist U; Wernroth ML; Husmark T; Larsson P; Geijer M; Teleman A; Theander E; Alenius GM
Clin Exp Rheumatol; 2017; 35(6):936-942. PubMed ID: 28628468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
